Blog Archive
-
▼
2010
(63)
-
▼
May
(9)
- Breathe Technologies Secures $23 Million in Series...
- Funxional Therapeutics : ...10 million Euros... to...
- Cardiocom : Telehealth Platform with New Pulse Oxi...
- Cytokinetics : Non-Clinical Data from Its Smooth M...
- Galapagos and Roche : COPD alliance
- Cellceutix : Important New Data on Kevetrin(TM) i...
- Nabriva Therapeutics : successful Phase I clinical...
- NexBio : Clinical Trial of DAS181 (Fludase®*) in A...
- Mylan Pharmaceuticals : Approval for Generic Versi...
-
▼
May
(9)
May 28, 2010
Breathe Technologies Secures $23 Million in Series C Financing
May 18, 2010 - John Miclot elected chairman; FDA clearance received - Breathe Technologies, Inc., a manufacturer of innovative technology solutions for people with respiratory conditions, including chronic obstructive pulmonary disease and sleep apnea, announced it has secured $23 million in Series C financing. The financing was led by DAG Ventures and included Kleiner Perkins Caufield & Byers (KPCB), Delphi Ventures, Synergy Partners International and Johnson & Johnson Development Corporation. Additionally, industry leader John L. Miclot joined as chairman of the board, and the company received FDA 510(k) clearance for its wearable ventilation system... [PDF] Breathe Technologies' Press Release -